LIR-containing proteins in Mus musculus>> EXPORT DATA
S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component |
1 | A0A504 | 30 | 35 | KDWEAV | 21 | ||||
2 | A0JNS2 | 97 | 102 | LVYDAI | 7 | ||||
3 | A0JNT9-2 | 97 | 102 | LGFLIL | 10 | ||||
4 | A0JP43 | 231 | 236 | EDFDAL | 16 | ||||
5 | A0JP43-2 | 231 | 236 | EDFDAL | 16 | ||||
6 | A0JP43-3 | 231 | 236 | EDFDAL | 16 | ||||
7 | A1EGX6 | 71 | 76 | KEYESL | 13 | TBCD5_HUMAN(57-62) KEWEEL(4) | protein binding (GO:0005515) |
||
8 | A1L3T7 | 530 | 535 | LEYQVL | 12 | ||||
9 | A2A259 | 702 | 707 | EEFDML | 15 | protein binding (GO:0005515) |
endoplasmic reticulum (GO:0005783) |
||
10 | A2A3Z2 | 438 | 443 | DTYDIV | 15 | nucleic acid binding (GO:0003676); protein binding (GO:0005515) |
nucleolus (GO:0005730); nucleus (GO:0005634) |
||
11 | A2A472 | 324 | 329 | SMWDSL | 19 | ||||
12 | A2A473 | 282 | 287 | SMWDSL | 19 | ||||
13 | A2A482 | 556 | 561 | DVYTAV | 9 | ||||
14 | A2A483 | 581 | 586 | DVYTAV | 9 | ||||
15 | A2A484 | 585 | 590 | DVYTAV | 9 | ||||
16 | A2A485 | 576 | 581 | DVYTAV | 9 | ||||
17 | A2A4N5 | 562 | 567 | LSFELL | 10 | ||||
18 | A2A4N5 | 748 | 753 | EDYIII | 17 | NBR1_HUMAN(730-735) EDYIII(6); TBC25_HUMAN(134-139) EDWDII(4) |
|||
19 | A2A4N5 | 897 | 902 | PSFLKI | 10 | ||||
20 | A2A4N7 | 562 | 567 | LSFELL | 10 | ||||
21 | A2A4N7 | 723 | 728 | EDYIII | 17 | NBR1_HUMAN(730-735) EDYIII(6); TBC25_HUMAN(134-139) EDWDII(4) |
|||
22 | A2A4N8 | 562 | 567 | LSFELL | 10 | ||||
23 | A2A4N8 | 711 | 716 | EDYIII | 17 | NBR1_HUMAN(730-735) EDYIII(6); TBC25_HUMAN(134-139) EDWDII(4) |
|||
24 | A2A5Y6 | 16 | 21 | GDYTLL | 15 | protein binding (GO:0005515) |
nucleus (GO:0005634) |
||
25 | A2A6P6 | 116 | 121 | FSFQAL | 11 | ||||
26 | A2A6Q8 | 110 | 115 | EMFLPI | 11 | ||||
27 | A2A761 | 13 | 18 | ATWVKL | 18 | nucleic acid binding (GO:0003676) |
intracellular (GO:0005622) |
||
28 | A2A791 | 20 | 25 | AVFDEI | 8 | FYCO1_HUMAN(1278-1283) AVFDII(5) | |||
29 | A2A791 | 987 | 992 | PVFVPI | 7 | ||||
30 | A2A791 | 1146 | 1151 | ESFDPL | 12 | ||||
31 | A2A791-2 | 20 | 25 | AVFDEI | 8 | FYCO1_HUMAN(1278-1283) AVFDII(5) | |||
32 | A2A791-2 | 898 | 903 | PVFVPI | 7 | ||||
33 | A2A791-2 | 1057 | 1062 | ESFDPL | 12 | ||||
34 | A2A7H6 | 166 | 171 | GGFTHI | 10 | ||||
35 | A2A7Y5 | 322 | 327 | LGWDIL | 18 | ||||
36 | A2A7Y5-2 | 322 | 327 | LGWDIL | 18 | ||||
37 | A2A826 | 32 | 37 | LSFVEL | 11 | BNI3L_HUMAN(34-39) SSWVEL(4); OPTN_HUMAN(176-181) DSFVEI(4) |
|||
38 | A2A828 | 32 | 37 | LSFVEL | 11 | BNI3L_HUMAN(34-39) SSWVEL(4); OPTN_HUMAN(176-181) DSFVEI(4) |
|||
39 | A2A829 | 32 | 37 | LSFVEL | 11 | BNI3L_HUMAN(34-39) SSWVEL(4); OPTN_HUMAN(176-181) DSFVEI(4) |
|||
40 | A2A830 | 32 | 37 | LSFVEL | 11 | BNI3L_HUMAN(34-39) SSWVEL(4); OPTN_HUMAN(176-181) DSFVEI(4) |
|||
41 | A2A863 | 1643 | 1648 | LVFTAL | 5 | cell adhesion (GO:0007155) |
cell leading edge (GO:0031252); receptor complex (GO:0043235) |
||
42 | A2A863-2 | 1578 | 1583 | LVFTAL | 5 | ||||
43 | A2A863-3 | 1631 | 1636 | LVFTAL | 5 | ||||
44 | A2A864 | 1627 | 1632 | LVFTAL | 5 | cell adhesion (GO:0007155) |
cell leading edge (GO:0031252); cell surface (GO:0009986); receptor complex (GO:0043235) |
||
45 | A2A884 | 110 | 115 | STWQLV | 17 | nucleus (GO:0005634) |
|||
46 | A2A884 | 1304 | 1309 | AMYTTL | 12 | nucleus (GO:0005634) |
|||
47 | A2A891 | 522 | 527 | FGFTSV | 10 | TBCD5_HUMAN(785-790) SGFTIV(4) | nucleus (GO:0005634) |
||
48 | A2A891-2 | 522 | 527 | FGFTSV | 10 | TBCD5_HUMAN(785-790) SGFTIV(4) | |||
49 | A2A891-5 | 522 | 527 | FGFTSV | 10 | TBCD5_HUMAN(785-790) SGFTIV(4) | |||
50 | A2A8K5 | 594 | 599 | SGYVTL | 14 |